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Abstract The debate over genetically modified (GM) crops has
raged in Europe since 1996, but had barely risen above a whisper
in the USA until recent labeling debates raised public attention.
This article will explain GM crops and traits discuss safety
assessment provide a view on safety from authoritative organi-
zations discuss selected issues of current debate, and provide the
author’s perspective as to why the public debate has drifted so far
from scientific reality. The economic and environmental benefits
of GM crops are beyond scope, but references are provided. GM
food and feed undergo comprehensive assessments using recog-
nized approaches to assure they are as safe as the conventional
congener. Issues of food safety and nutrition, unrelated to theGM
process, may arise when GM foods display novel components or
composition. Unanticipated genetic effects in GM crops appear
to be limited in contrast to existing variations among conven-
tional varieties resulting from breeding, mutation, and natural
mobile genetic elements. Allergenic potential is assessed when
selecting genes for introduction into GM crops and remains a
theoretical risk to date. Emerging weed and insect resistance is
not unique to GM technology and will require the use of inte-
grated pest management/best practices for pest control. Gene
flow from GM crops to wild relatives is limited by existing
biological barriers but can at time be a relevant consideration in
gene selection and planting practices. Insect-resistant GM crops
have significantly reduced use of chemical insecticides and
appear to have reduced the incidence of pesticide poisoning in
areas where small scale farming and hand application are com-
mon. Changes in herbicide patterns are more complex and are
evolving over time in response to weed resistance management
needs. Recent public debate is driven by a combination of
unfounded allegations about the technology and purveyors, pseu-
doscience, and attempts to apply a strict precautionary principle.
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Public opinion
The public debate over genetically modified (GM) crops has
raged in Europe since their introduction in 1996, but had
barely risen above a whisper in the USA until the recent
California [1] andWashington [2] GM labeling debates raised
public attention. If the issue has not entered your world as a
medical toxicologist, it may do so soon—either as a debate
about GM crops or about the pesticides used with them. This
article will explain GM crops and the traits they contain,
discuss safety assessment, provide a view on safety from
authoritative organizations, discuss selected current matters
of legitimate scientific debate such as food safety of compo-
sitionallymodified crops and the emergence of pest resistance,
and provide the author’s perspective as to how the public
debate has drifted so very far from scientific reality. The
economic and agronomic impacts of GM crops as well as
environmental topics not included here have been reviewed
elsewhere [3–6].
Current GM Crops and Safety Assessment
GMcrops in use today [3] are largely global commodity crops—
maize, soybean, cotton, canola, sugar beet, and alfalfa, alongside
a number of nutritionally improved oils such as omega-3
(stearidonic acid, 18:3, n-3) containing soybean oil. Direct hu-
man consumption of GM crops is generally limited to sweet
corn, papaya, and squash and to consumption of processed
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fractions (oil, protein, sugar, etc.) derived from GM crops. New
genetic material in GM crops is incorporated into the plant’s
primary genome and in most cases is transcribed to mRNA and
subsequently translated to an effector protein. However, viral
resistance and some nutritional traits are the result of RNA-
mediated gene regulation, with no novel protein production.
DNA and RNA are normal dietary components and present no
recognized hazard [7].
Primary GM traits include herbicide tolerance, insect resis-
tance, viral resistance, and nutritional enhancements. Herbicide
tolerance facilitates the use of herbicides over GM crops (such
as maize, soybean, canola, cotton, and sugar beet), allowing the
crop to remain uninjured while weeds are controlled. Tolerance
to glyphosate is the leading commercial herbicide-tolerant trait.
Glyphosate inhibits the EPSPS (enyol-pyruvate-shikimate-3-
phosphate synthase) [8], the first step in the synthesis of aro-
matic amino acids essential for plant growth and survival.
Glyphosate tolerance is mediated by a bacterial EPSPS gene
unaffected by glyphosate [8]. Glufosinate tolerance results from
the introduction of an acetyltransferase which inactivates the
herbicide [8]. Crops tolerant to other herbicides are commer-
cially available (glufosinate, 2,4-D) or under development and
undergoing regulatory review (dicamba) [8].
Insect resistance is available in maize, cotton, soybean, and
brinjal (eggplant) [8]. Resistance is conferred by a variety of
Cry (crystal) or VIP (vegetative) insecticidal proteins
(Cry1Ac, Cry3Bb, Vip3A, etc.) derived from multiple strains
of Bacillus thuringiensis (Bt) [8]. Bt is a naturally occurring
organism used as an insecticide in conventional and organic
agriculture for over 50 years. Viral resistance is RNA-
mediated (RNAi directed at viral capsid proteins, mimicking
the natural plant-defense mechanism) [8]. Altered nutrient
composition can be created via RNA-induced gene suppres-
sion or by introduction of enzymes conducting desired bio-
chemical reactions [8].
In the USA, GM crops are conjointly regulated by the FDA
(food and feed safety), USDA (plant pest risks), and EPA
(pesticidal products) under an established inter-agency agree-
ment [9]. There is no specific US Federal legislation regarding
GM food safety. All food must be safe (no unreasonable risk
of harm under anticipated conditions of use), and GM crops,
foods, and ingredients must be as safe as their conventional
counterparts. Thus, FDA has the authority to regulate GM
food and feed and always has jurisdiction to prevent the sale of
any foods/feed it deems to be adulterated. While there is a
theoretical pathway to market (self-GRAS determination)
which could bypass FDA review, every commercial GM crop
has been voluntarily submitted by industry for an FDA
premarket safety assessment. The fact that safety assessment
of GM crops is mandatory in most jurisdictions outside of the
USA, often contingent on prior US approval, assures that pre-
market assessment will remain the de facto standard approach
to US regulation.
No whole food category in history has been as thoroughly
examined as GM crops—only chemical food additives receive
greater scrutiny. Pre-market food and feed safety assessment is
based on internationally recognized approaches and must
demonstrate that GM crops are as safe as their conventional
counterparts for food and feed use [10–12] and present no
unacceptable risk to the environment [13]. The process begins
with a comparative assessment to identify similarities (re-
ferred to as substantial equivalence) and differences between
the newly developed GM crop and a conventional counterpart
with a long history of safe use. Any actual or suspected
differences then become the focus of the food, feed, and
environmental safety assessment. The assessment [10, 11]
begins with careful selection of gene source to avoid allergen-
ic and potentially toxic sources. Food and feed assessment
generally focuses on safety of the introduced protein. Bioin-
formatic (DNA and protein sequence) analysis assures lack of
homology to allergens or toxins, and heat stability and digest-
ibility analyses ensure a lack of digestive stability. Acute
protein toxicity studies as well as 28- or 90-day whole crop
studies are routinely performed in rodents, and livestock stud-
ies provide additional assurance of nutritional performance.
The crop is subjected to detailed compositional analysis,
including known toxins and anti-nutrient factors, “proximate
analysis” (total protein, carbohydrate, ash, mineral content,
etc.), and analysis of fatty acids, amino acids, vitamins, and
minerals—all to assure that the composition of the GM crop
falls well within the range of expected values for the conven-
tional crop.
For GM crops with altered or novel compositional aspects
(e.g., nutritionally modified oils), a comprehensive safety
assessment is undertaken for any changes made, considering
both individual health and population nutritional impacts.
Unanticipated genetic effects can occur with any breeding
technique, and the absence of relevant unanticipated effects
can be demonstrated by studies to assure proper gene inser-
tion, composition, and agronomic performance. Fifteen years
of studies demonstrate considerably more variability among
conventional crops due to genetics and environment than
results from transgene insertion in a particular variety; recent
genomics studies demonstrate that gene insertion produces
minor perturbations of overall gene function compared to
dramatic differences in expression across crop varieties, loca-
tions, and growing conditions (see below).
Despite this scrutiny, concern is often expressed that no
long-term studies with GM crops have been performed.While
this is not correct [14], it is also important to recognize that
DNA, RNA, and protein are normal dietary components.
There are no examples of dietary DNA, RNA, or digestible
protein having carcinogenic or reproductive toxicity, and
long-term testing to detect these outcomes is neither necessary
nor informative. Acute toxicity testing is done using suffi-
ciently high dose (up to 2,000-mg protein/kg body weight) to
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ensure adequate margins of safety (thousands of times greater
than intake). To keep this in perspective, recall that there are
tens of thousands of proteins in maize alone—hundreds of
thousands in a normal diet—none of which have ever been
subjected to long-term testing.
Legitimate Scientific Debate
Before turning to the increasingly loud public debate on GM
crops, it is worth pausing to identify some areas for which
legitimate scientific concerns have been expressed. Few of
these issues revolve around human health for precisely the
reasons discussed above—currently implemented GM crops
introduce DNA, RNA, and digestible proteins with a history
of safe use into the diet following extensive regulatory review,
and are thus unlikely to have associated safety concerns. The
topics below are currently in public debate and thus of possi-
ble interest to readers. Given available space, this is not a
comprehensive list and is not intended to suggest that other
issues necessarily lack in scientific merit.
Food-safety-related issues may arise in the context of GM
crops with significant alterations in nutrient composition or
with novel dietary components. These issues have little to do
with GM technology as they relate primarily to impacts on
overall dietary consumption patterns and the safety of specific
food components. Appropriate safety assessment is nonethe-
less warranted. For example, the introduction of high-oleic,
low-linolenic soybean oil for use in fast-food frying applica-
tions can reduce saturated fat intake [15]. No new dietary
component is introduced in this product, which results from
RNA-mediated gene regulation and conventional breeding
and which contains no novel protein [15]. On first blush,
one might think no safety issues arise. However, it is reason-
able to ask whether widespread use would result in inadequate
intake of essential fatty acids in humans, as the oil has reduced
levels of linoleic and alpha-linolenic acids. This question was
addressed with detailed market modeling to establish no sig-
nificant effect on essential fatty acid intake [15].
Similarly, the introduction of omega-3 fatty acid containing
soybeans enhanced with stearidonic acid (SDA) [16] raises
questions about the safety of SDA as a food component. SDA
is an 18-carbon fatty acid with four double bonds (18-4, n-3).
Conversion of alpha-linolenic acid (ALA; 18-3, n-3) to SDA
is the first and rate-limiting step in conversion of ALA to the
long-chain fatty acid, eicosapentaenoic acid (EPA) found in
fish oil [16, 17] and is expected to provide heart health
benefits as a result of conversion to EPA [17]. As such, it is
a normal metabolic intermediate in humans. However, only
traces of SDA can be found in humans and very little SDA
occurs in the human diet. Consequently, SDA soybean oil
underwent studies, including a 28-day sub-chronic rat toxicity
study with 90-day reproductive and developmental toxicity
[18], to establish safe levels of intake in rodents; and SDA
soybean oil was subjected to GRAS determination with for-
mal FDA review.
Unanticipated genetic effects of GM technology have been
alleged to raise food safety issues. It has long been recognized
that conventional technologies (which include wide or forced
crosses, plant embryo rescue, and chemical or radiation in-
duced mutagenesis) can also result in unanticipated phenom-
enon and that the risk of GM technologies falls within the
range of risks entailed with conventional methods [19]. In the
last several years, genomic technology has documented that
the GM process itself produces only small changes in overall
gene expression and proteomics in the transformed plant when
compared to the large degree of variation introduced by nat-
ural genomic instability [20] and by conventional breeding
processes and environmental effects [20–27].
Food allergy has also been raised as a potential issue in GM
crops. GM crops are, of course, as allergenic as conventional
crops as no allergenic components have been removed. As of
this writing, there has been no documented occurrence of
allergy to an inserted GM protein. Approaches to allergenicity
assessment in GM crops have been reviewed elsewhere [28].
By way of summary, when selecting proteins for use in GM
crops, we avoid known allergenic sources such as tree nuts;
using bioinformatic approaches, we avoid known food aller-
gens as well as proteins having sequence similarity (eight or
more amino acids) to known food allergens; and proteins are
screened for heat stability and poor digestibility, two charac-
teristics often found in allergenic proteins. Food allergy re-
duction is theoretically feasible using GM technology [29],
but has not yet been developed commercially. It is the author’s
view that in the unlikely event that a major food allergen is
engineered into a GM crop, it would be removed from com-
mercial use; an option we do not have with most existing,
naturally occurring allergens. Thus, the GM allergenicity de-
bate appears to place undue focus on a theoretical and reme-
diable risk while major allergenic foods remain unrestricted
(albeit labeled) in the market place.
A complete discussion of the environmental aspects of GM
crops is beyond the scope of this paper, but a few recent issues
are worthy of note. Given that medical toxicologists are likely
less familiar with agronomic and environmental issues, refer-
ences provided in this section are more introductory in nature.
Agronomically important insect resistance to Bt toxins has
emerged as a practical issue in corn rootworm management
using single Bt genes for insect control in the upper Midwest-
ern USA [30] and in pink bollworm in India [31], and evi-
dence of field selection for resistance (without clear emer-
gence of heritably resistant populations) has been identified in
other species in specific regions [32]. While single traits
remain an effective management tool in most locations, the
incidence of resistance highlights the need for broader man-
agement strategies, commonly called integrated pest
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management (IPM) or best management practices (BMP).
IPM/BMP takes advantage of agricultural interventions (for
example, crop rotation) in conjunction with conventional pes-
ticides and multi-trait GM crops with multiple modes of action
to limit the emergence of resistant strains, while monitoring
for and aggressively managing local resistance where and
when it occurs (see, for example, US EPA [33]). This ap-
proach approximates the approach we take for management of
microbial resistance in hospital environments—altering the
environment to reduce effective transmission while simulta-
neously employing high doses and multiple modes of action
to limit resistance emergence and isolating and managing
outbreaks of resistant strains.
Weed management is not just a cosmetic issue for farmers—
weed competition for resources in the field results in major
yield loss if management issues are not properly addressed [34].
Weed resistance to glyphosate, widely used in GM crops, has
become an issue with selected weed types and in particular
locations over the past decade [32, 35]. This is, as with the food
safety issues, less a matter of GM technology itself and more a
matter of chemical use patterns. The proliferation of glyphosate
tolerant crops has increased the intensity of glyphosate use and
has indirectly contributed to this issue [35]. However, herbicide
resistance has arisen spontaneously to essentially all classes of
herbicide chemistry long before the existence of GM crops
[36]. Management techniques [35–37] closely parallel those
used in insect resistance: employ multiple chemistries with
independent modes of action and apply maximal permitted
rates to limit emergence of resistance, employ agronomic prac-
tices (mechanical tillage, spot herbicide application, hand
weeding) to limit propagation of resistant lines, and monitor
for and aggressively manage resistance when and where it
occurs. This, of course, has ramifications for overall patterns
of herbicide use as discussed below.
Another topic of debate is the possibility of gene flow [38,
39]. Gene flow is the transfer of genetic material (genes) from
one population to another [40] and can occur, depending on the
plant species, by the relocation of asexual propagules (e.g.,
tubers) or seed outside of cultivation to produce wild populations
or alternatively by sexual reproduction (pollination) [41]. Gene
flow is a natural occurrence [42] and is not an inherently adverse
phenomenon [40]. Gene flow fromGMcrops has not lead to any
recognized health or environmental problems [40].
Gene flow from crop plants began approximately
10,000 years ago with the domestication of crops [39, 41],
during which wild plants were selected for several traits termed
the “domestication syndrome” [43]. Some domestication traits
limit gene flow. For example, increased seed retention (reduced
“shattering”) in crops increases harvest yields and decreases
seed-mediated gene flow [40]. Modern cultivated varieties of
maize do not occur outside of cultivation and thus, maize is not
consideredweedy or invasive [41]. However, other crop species
have domesticated wild and weedy forms as is the case for
sugar beet in Europe [41]. Although most crops have limited
seed dispersal mechanisms, seed-mediated gene flow can occur
by seed loss during transportation, as occurs with canola (oil-
seed rape). Dispersed canola populations typically occur in
human-disturbed habitats such as roadsides and railways, but
do not persist without continual replenishment of the seed bank
by human activities because canola does not effectively com-
pete with perennial vegetation in the absence of ongoing dis-
turbances [44, 45]. No differences in soil seed persistence
between transgenic herbicide-tolerant and conventional canola
have been demonstrated [46–50].
Pollen-mediated gene flow from GM to non-GM crops or
to related species has also received significant attention [32].
Pollen may move from GM to non-GM crops in close prox-
imity, with the amount of actual gene flow dependant on
distance and reproductive biology. While the organic industry
has decided not to use GM seed and some growers are con-
cerned pollen-mediated gene flow, this can be managed suc-
cessfully to enable coexistence with cooperation among adja-
cent growers [41].
Pollen-mediated gene flow to non-crop species has been
extensively reviewed [41]. Gene flow from crops to weeds has
occurred historically and has been implicated in the evolution
of enhanced weediness for some species in some geographic
regions [51] but did not involve GM crops. For hybridization
to occur, related genetically compatible species must be pres-
ent in the environment. Thus, pollen-mediated gene flow from
maize or soybean to related species is not a concern in the
USA, because there are no cross compatible relatives [32].
Wild relatives may exist in areas of crop origin as with, for
example, maize in Mexico [41]. Although the presence of a
wild relative creates the possibility of gene flow, it does not
mean that gene flow will necessarily occur [41], as the crop
and a sexually compatible relative must flower at the same
time [52] and pollen must germinate, grow, and fertilize the
ovule to produce a viable seed. The resulting first generation
hybrids must then germinate and either self-pollinate or back-
cross to the related species multiple times to facilitate intro-
gression—the established and sustained transfer of a gene
from one population into another [38, 52]. There are several
barriers to successful hybridization and introgression, includ-
ing sterility and reduced fitness of a hybrid in the environment
[53]. As noted above, traits associated with the domestication
syndrome may limit hybrid fitness in nature [38]. Further, any
fitness change to a crop relative associatedwith a GM trait will
not necessarily result in increased fitness, weediness, or inva-
siveness (recall that the GM gene does not transfer alone—
fully, half of the genetic content of the hybrid derives from the
domesticated crop). Changes may be detrimental, and some
traits may be neutral (provide no benefit or detriment), as with
herbicide tolerance in a habitat without the herbicide applica-
tion [41]. Thus, each crop and trait combination requires a
rigorous environment risk assessment to evaluate both the
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potential for gene flow to related species and the conse-
quences of gene flow if it were to occur [13]. In some
instances, these considerations have, in fact, delayed or limit-
ed the deployment of GM crops [32].
Finally, it is worth noting the current pesticide-use-
reduction debate. A major advantage of Bt insect control has
been a dramatic reduction in the need for conventional small-
molecule insecticides over Bt commodity crops—most partic-
ularly corn and cotton [5, 32]. This has resulted in a net
reduction estimated at 50 million kilograms of predominantly
organophosphate insecticides (1996–2011) [5] and is a con-
siderable advantage in areas where small-holder agriculture is
the norm and application is often by hand as indicated by
reductions in pesticide poisoning events [54, 55].
The use of glyphosate tolerant crops initially produced a
significant reduction in the use of non-glyphosate herbicides
and in total herbicide use [5]. In addition, the use of glypho-
sate for weed management has generally resulted in displace-
ment of herbicides with less favorable toxicological and envi-
ronmental characteristics [32]. The emergence of weed resis-
tance has necessitated the increased use of maximum-rate
glyphosate applications and has also increased the necessity
for alternative herbicides either in conjunction with crops
having a broader spectrum of herbicide tolerance
(glyphosate, glufosinate, and 2,4-D with dicamba under
development) or independent of GM systems [32]. The choice
to use herbicide-tolerant cropping systems provides economic
and ecological benefits (including promotion of biodiversity)
[56] as a result of conservation tillage and other factors [5] and
provides additional options for integrated pest management
[5, 32], but annual “pounds on the ground” reductions in
herbicide use have clearly eroded with the need for weed
resistance management (discussed above) [32].
These environmental issues are, on the one hand, real and
quite worthy of discussion and debate. They are, however,
extensions of ongoing issues already present in conventional
agriculture. While there is a clear need to address these issues
effectively, this does not appear to necessitate rejection of GM
technology as a whole. Rather, the role of GM technology—
and various conventional technologies—in agriculture should
continue to evolve in response to an evolving environment
and in response to continued technical and scientific develop-
ments, genetic, and otherwise [6, 32].
The current public debate
Authoritative organizations such as the FDA, World Health
Organization, AAAS, the Royal Society of Medicine, and the
National Academy of Science have affirmed the safety of GM
crops [9, 19, 57–60]. So, how did the public conversation on
GM crops become so negative? Opponents of GM have used
three approaches to drive negative public opinion. The first
approach has been to create negative impressions about the
developers and purveyors of this technology, particularly
Monsanto (a Google image search for Monsanto vs. the other
major agrochemical companies will provide insight!). At a
recent medical meeting, three issues repeatedly arose in casual
conversation: (a) Monsanto’s GM crops produce seeds that are
sterile (untrue, as are rumors that we developed or use the
“terminator” gene [61]), (b) Monsanto sues farmers for inad-
vertent wind-blown pollination (untrue—Monsanto has sued a
small number of farmers who intentionally violated the GM
seed purchase agreement by saving and in some cases selling
GM seed [62]), and (c) Farmers in India are committing suicide
due to the increased economic burden resulting from GM crop
failure (unfounded allegation long refuted by studies performed
by the government of India and International Food Policy
Research Institute [63]). Unfortunately, these kinds of allega-
tions serve to undermine confidence in GM despite an exten-
sive body of scientific evidence to the contrary.
A second approach is to question the science underlying GM
safety, often via misinterpretation of data obtained in inappropri-
ate test systems. One recurrent example is the use of surfactant-
containing preparations in cell culture systems, “proving” that
glyphosate-surfactant products are endocrine disruptors since
they impair hormone production. In fact, these systems demon-
strate surfactant-mediated disruption of mitochondria, and the
authors have simply chosen hormone production as a politically
expedient endpoint for cellular asphyxia [64]. Data from more
routine systems can also be misinterpreted. A recent egregious
example is the now-withdrawn rodent study by Seralini et al. [65]
demonstrating tumors and early death in rats—a study not just
published but “launched” with a press event, book publication,
and videos in three languages. While the pictures are dramatic,
no statistics were performed and the findings were within expec-
tation for Sprague-Dawley rats [66 and associated annexes].
Regulatory agencies around the globe wasted untold hours re-
butting and explaining these findings. One can also get traction
simply by spinning unfounded theories. For example, Samsel
and Seneff [67], neither of whom has any background in the
biological sciences, published an article in a physics journal
(Entropy) arguing that GM crops and associated pesticides act
via “exogenous semiotic entropy” and lead to most of the dis-
eases and conditions associated with a Western diet, including
gastrointestinal disorders, obesity, diabetes, heart disease, depres-
sion, autism, infertility, cancer, and Alzheimer’s disease. Their
arguments were quickly rejected and derided, but not before they
gained a large amount of press and provided support to the many
unfounded fears of GMO’s.
A third approach is to invoke the “precautionary principle.”
As originally proposed, the principle stated that risk assessors
and policy makers should take account of uncertainties and
employ uncertainty factors when necessary to provide ade-
quate margins of safety [68]. The absolute version employed
by some suggests that in the presence of any uncertainty, we
should not move forward [69]. This is of course a “black
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hole”—one can never prove a negative and hence one can
never move forward when employing the absolute precaution-
ary principle. The latter ignores both the risks of existing
technology and the benefits of innovation and leaves decision
making in the hands of anyone who chooses to raise doubts.
GM crops have a more than 20-year track record of being
grown and used commercially without a single human illness
known to be caused byGM food or feed.Moreover, billions of
animals have been fed predominantly GM diets for consecu-
tive generations with no evidence that animal health and
productivity were affected. The safety assessment paradigm
for GM crops is robust and well established, and the approach
has been confirmed by authoritative regulatory agencies and
scientific organizations around the globe. These are, by far, the
most thoroughly assessed foods and feeds in human history,
and the National Academies of Science concluded that risk or
unintended effects of GM technologies falls within the range
of risks for conventional breeding technologies—which in-
clude forced inter-species crosses and radiation-induced mu-
tagenesis [19]. We can move forward with high confidence
that GM food and feed are as safe and nutritious as their
conventional congeners and perhaps look forward to rational-
izing food safety assessment across conventional, GM, and
other new breeding technologies to achieve a more focused
and resource-efficient safety assessment process.
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